Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden.
EPID Research, Metsänneidonkuja 12, FI-02130, Espoo, Finland.
BMC Pulm Med. 2018 Jan 25;18(1):17. doi: 10.1186/s12890-018-0573-0.
Exacerbations of chronic obstructive pulmonary disease (COPD) are an important measure of disease severity in terms of impaired disease progression, increased recovery time, healthcare resource utilization, overall morbidity and mortality. We aimed to quantify exacerbation and healthcare resource utilization rates among COPD patients in Sweden with respect to baseline treatments, exacerbation history, and comorbidities.
Patients with a COPD or chronic bronchitis (CB) diagnosis in secondary care at age of ≥40 years on 1.7.2009 were identified and followed until 1.7.2010 or death. Severe exacerbations were defined as hospitalizations due to respiratory disease, and healthcare resource utilization was measured by all-cause hospitalizations and secondary care visits. Poisson regression was used adjusting for age, gender, time since COPD/CB diagnosis, and Charlson comorbidity index.
In 88,548 patients (54% females, mean age 72 years), previous respiratory hospitalizations and current high use of COPD medication (double or triple therapy) predicted an 8.3-fold increase in severe exacerbation rates and 1.8-fold increase in healthcare resource utilization rates in the following year, compared to patients without combination treatment and/or history of severe exacerbations.
COPD/CB patients with history of severe exacerbations and high use of COPD medication experienced a significantly increased rate of severe exacerbations and healthcare resource utilization during the one-year follow-up.
慢性阻塞性肺疾病(COPD)的加重是衡量疾病严重程度的一个重要指标,会影响疾病进展、恢复时间、医疗资源利用、整体发病率和死亡率。我们旨在根据基线治疗、加重史和合并症,量化瑞典 COPD 患者的加重和医疗资源利用率。
在 2009 年 7 月 1 日,年龄≥40 岁的二级保健中患有 COPD 或慢性支气管炎(CB)的患者被确定,并随访至 2010 年 7 月 1 日或死亡。严重加重定义为因呼吸系统疾病住院,而医疗资源利用则通过全因住院和二级保健就诊来衡量。采用泊松回归,调整年龄、性别、COPD/CB 诊断后时间和 Charlson 合并症指数。
在 88548 名患者(54%为女性,平均年龄 72 岁)中,与未接受联合治疗和/或无严重加重史的患者相比,既往呼吸系统住院和当前 COPD 药物(双倍或三倍疗法)的高使用率预测下一年严重加重率增加 8.3 倍,医疗资源利用率增加 1.8 倍。
有严重加重史和高 COPD 药物使用率的 COPD/CB 患者在一年随访期间经历了严重加重和医疗资源利用率的显著增加。